Consonance Capital Management LP / UTHR
Consonance Capital Management LP’s United Therapeutics Corp Del Position
Does Consonance Capital Management LP own United Therapeutics Corp Del (UTHR)? Not currently — the last reported position was 3.0K shares worth $706,000 in Q2 2022; the fund’s latest 13F (Q3 2022) no longer reports it.
Position Value
$706,000
Q2 2022
Shares
3.0K
% of Portfolio
+2.98%
Quarters Held
12
position exited
Position History UTHR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2022 | 3.0K | $706,000 | +2.98% |
| Q1 2022 | 24.6K | $4M | +7.48% |
| Q4 2021 | 59.8K | $13M | +8.43% |
| Q3 2021 | 157.8K | $29M | +15.95% |
| Q2 2021 | 159.1K | $29M | +3.43% |
| Q1 2021 | 558.2K | $93M | +9.95% |
| Q4 2020 | 529.0K | $80M | +7.50% |
| Q1 2020 | 1.35M | $128M | +9.53% |
| Q4 2019 | 919.3K | $81M | +4.94% |
| Q3 2019 | 967.6K | $77M | +7.64% |
| Q2 2019 | 770.8K | $60M | +4.26% |
| Q1 2019 | 1.23M | $144M | +9.08% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Consonance Capital Management LP’s full portfolio or all institutional holders of UTHR.